We have recently found that either arginine depletion or neutrophil-released arginase-1 highly potentiates the antitumor action of the ER-targeting antitumor ether lipid edelfosine against pancreatic cancer cells [239], opening up new avenues for cancer treatment. Here, ARG1 is linked to familial pancreatic carcinoma.